1.05 USD
-0.03 (-2.78%)
1.06 USD
+0.01 (+0.95%)
Taking everything into account, DCGO scores 3 out of 10 in our fundamental rating. DCGO was compared to 101 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DCGO has reported negative net income.
In the past year DCGO had a positive cash flow from operations.
Of the past 5 years DCGO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
DCGO's Return On Assets of -14.58% is on the low side compared to the rest of the industry. DCGO is outperformed by 78.22% of its industry peers.
DCGO has a worse Return On Equity (-19.07%) than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of DCGO has declined.
DCGO's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 31.21%, DCGO perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
In the last couple of years the Gross Margin of DCGO has remained more or less at the same level.
DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DCGO has been reduced compared to 1 year ago.
Compared to 1 year ago, DCGO has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.38, we must say that DCGO is in the distress zone and has some risk of bankruptcy.
DCGO has a worse Altman-Z score (1.38) than 65.35% of its industry peers.
The Debt to FCF ratio of DCGO is 0.32, which is an excellent value as it means it would take DCGO, only 0.32 years of fcf income to pay off all of its debts.
DCGO has a better Debt to FCF ratio (0.32) than 94.06% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that DCGO is not too dependend on debt financing.
DCGO's Debt to Equity ratio of 0.04 is amongst the best of the industry. DCGO outperforms 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 1.38 |
ROIC/WACCN/A
WACC8.43%
2.3 Liquidity
DCGO has a Current Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Current ratio of 2.59 is amongst the best of the industry. DCGO outperforms 84.16% of its industry peers.
DCGO has a Quick Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of DCGO (2.59) is better than 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.14%.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
Looking at the last year, DCGO shows a very negative growth in Revenue. The Revenue has decreased by -47.03% in the last year.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
3.2 Future
The Earnings Per Share is expected to decrease by -39.69% on average over the next years. This is quite bad
The Revenue is expected to decrease by -17.73% on average over the next years. This is quite bad
EPS Next Y-264.77%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue Next Year-49.2%
Revenue Next 2Y-28.89%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, DCGO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.98 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -39.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.05
-0.03 (-2.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners52.39%
Inst Owner Change-4.12%
Ins Owners7.1%
Ins Owner Change0.47%
Market Cap102.70M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.46
Price Target2.81 (167.62%)
Short Float %4.66%
Short Ratio1.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)-10.57%
PT rev (3m)-10.57%
EPS NQ rev (1m)-5.41%
EPS NQ rev (3m)-2.63%
EPS NY rev (1m)5.41%
EPS NY rev (3m)-3.28%
Revenue NQ rev (1m)-1.69%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.28 | ||
| P/FCF | 1.98 | ||
| P/OCF | 1.78 | ||
| P/B | 0.38 | ||
| P/tB | 0.49 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)0.53
FCFY50.47%
OCF(TTM)0.59
OCFY56.29%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.58% | ||
| ROE | -19.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.21% | ||
| FCFM | 14.08% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.73% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z | 1.38 |
F-Score4
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-264.77%
EPS Next 2Y-63.99%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.2%
Revenue Next 2Y-28.89%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-159.15%
EBIT Next 3Y-57.49%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A
DOCGO INC / DCGO FAQ
What is the fundamental rating for DCGO stock?
ChartMill assigns a fundamental rating of 3 / 10 to DCGO.
Can you provide the valuation status for DOCGO INC?
ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.
How profitable is DOCGO INC (DCGO) stock?
DOCGO INC (DCGO) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for DCGO stock?
The Earnings per Share (EPS) of DOCGO INC (DCGO) is expected to decline by -264.77% in the next year.